| Article Title |
Type |
 |
 |
|
Systemic
Sclerosis: a Prototypic Multisystem Fibrotic Disorder
(March 2007) – posted
3/8/07
by John Varga, M.D. and Dr. David Abraham, "J.
Clin. Invest." 117:557-567 (2007) |
|
Article |
|
"The
Role of Anti-Endothelial Cell Antibody-Mediated
Microvascular Injury in the Evolution of Pulmonary
Fibrosis in the Setting of Collagen Vascular Disease,"
by Cynthia M. Magro, M.D.1; Clay
B. Marsh, M.D.2; James N. Allen, M.D.2;
Patrick Ross, M.D.3; David Liff, M.D.4;
Deborah A. Knight, MS.c.5; W. James
Waldman, Ph.D.5; Tibor Nadasdy, M.D.5;
Daniel J. Cowden, M.D.,5 March 1, 2007. |
|
Article (4 sections) |
|
"Stem
Cell Benefits Persist In Scleroderma Patients"
(March 2006) – posted
3/20/06
by Nancy Walsh, "Rheumatology News"
Volume 5, Issue 3, Page 1,30 |
|
Article |
|
"A
Randomized Trial of Inhaled Cyclosporine in Lung-Transplant
Recipients" (2006)
by: Aldo T. Iacono, M.D.; Bruce
A. Johnson, M.D.; Wayne F. Grgurich, B.S.; J.
Georges Youssef, M.D.; Timothy E. Corcoran, Ph.D.;
Deidre A. Seiler, M.S.N.; James H. Dauber, M.D.;
Gerald C. Smaldone, M.D., Ph.D.; Adriana Zeevi,
Ph.D.; Samuel A. Yousem, M.D.; John J. Fung, M.D.,
Ph.D.; Gilbert J. Burckart, Pharm.D.; Kenneth
R. McCurry, M.D.; and Bartley P. Griffith, M.D. |
|
Abstract |
|
"Immunoproteasome
Subunit LMP2 Expression Is Deregulated in Sjögren's
Syndrome but Not in Other Autoimmune Disorders"
(2006)
Sabine Krause1, Ulrike Kuckelkorn2,
Thomas Dörner3, Gerd R Burmester3,
Eugen Feist3, and Peter M Kloetzel2
1Friedrich-Baur-Institute, Germany
2Institute of Biochemistry, Charite
University Hospital, Germany
3Charite University Hospital, Germany
|
|
Abstract |
|
"Distinct
Recognition of Antibodies to Centromere Proteins
in Primary Sjögren's Syndrome Compared with
Limited Scleroderma" (2006)
by Allan C Gelber1, Stanley R Pillemer
2, Bruce J Baum 2, Fredrick
M Wigley 1, Laura K Hummers 1,
Steven Morris 1, Antony Rosen 1,
and Livia A Casciola-Rosen 1
1Johns Hopkins University, United States
2NIDCR, United States |
|
Abstract |
|
"Lipoprotein[a]
and the Lipid Profile in Patients with Systemic
Sclerosis" (2005) – posted
April 18, 2006
by Giuseppe Lippi a,*, Paola Caramaschi
b, Martina Montagnana a, Gian
Luca Salvagno a,
Alessandro Volpe b, Giancesare Guidi
a
aInstituto di Chimica
e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche,
Universita` degli Studi di Verona, Ospedale Policlinico
G.B. Rossi, Piazzale Scuro, 10, 37134 — Verona,
Italy
bDipartimento
di Medicina Clinica, Sezione di Medicina Interna
B, Universita` degli Studi di Verona, Verona, Italy |
|
Article |
|
"Absence
of Autoantibodies Against Correctly Folded Recombinant
Fibrillin-1 Protein in Systemic Sclerosis Patients"
(2005) – Posted 3/27/2006
by Jürgen Brinckmann1 , Nico Hunzelmann2,
Ehab El-Hallous3, Thomas Krieg2,
Lynn Y Sakai4, Sven Krengel1
and Dieter P Reinhardt5
1Department of Dermatology, University
of Lübeck, Lübeck, Germany
2Department of Dermatology, University
of Cologne, Cologne, Germany
3Department of Medical Molecular Biology,
University of Lübeck, Lübeck, Germany
4Department of Biochemistry and Molecular
Biology and Shriners Hospital for Children, Oregon
Health and Science University, Portland, OR, USA
5Department of Anatomy and Cell Biology
and Faculty of Dentistry, McGill University, Montreal,
Canada
"Arthritis Research & Therapy"
2005, 7:R1221-R1226 doi:10.1186/ar1813 |
|
Article |
|
"Local Hyperhemia
to Heating Is Impaired in Secondary Raynaud's
Phenomenon" (2005) – Posted
3/27/2006
by Aude Boignard, Muriel Salvat-Melis, Patrick
H Carpentier, Christopher T Minson, Laurent Grange,
Catherine Duc, Françoise Sarrot-Reynauld,
and Jean-Luc Cracowski |
|
Article |
|
"Radiological
Hand Involvement in Systemic Sclerosis" (Dec.
2005)
by Jerome Avouac1, Henri Guerini2,
Julien Wipff1, Noemie Assous1,
Alain Chevrot3, Andre Kahan1,
and Yannick Allanore1
1Rheumatology A, Paris Descartes University,
Medical Faculty, Cochin Hospital, AP-HP, Paris,
France
2 Radiology B, Paris-Descartes University,
Medical Faculty, Cochin Hospital, AP-HP, Paris,
France
3 Radiology B, Paris Descartes University,
Medical Faculty, Cochin Hospital, AP-HP, Paris,
France |
|
Abstract |
|
| "Prevalence
of Sicca Symptoms and Secondary Sjogren's Syndrome
in Systemic Sclerosis" (2005)
by Jérome Avouac1, Marc Ardizonne2,
Christelle Sordet2, Caroline Depinay3,
Marie-Cécile Vacher-Lavenu3,
Jean Sibilia2, André Kahan1,
Yannick Allanore1. 1Rheumatology
A, Cochin Hospital, AP-HP, Paris 5 University,
Paris, France; 2Rheumatology- Hautepierre
CHU- Louis Pasteur 1 University, Strasbourg, France;
3Pathology, Cochin Hospital, AP-HP,
Paris 5 University, Paris, France. |
|
Abstract |
|
| "Shared
Expression of Phenotypic Markers in Systemic Sclerosis
Indicates a Convergence of Pericytes and Fibroblasts
to a Myofibroblast Lineage in Fibrosis" (2005)
By: Vineeth S. Rajkumar, Kevin Howell, Katalin
Csiszar, Christopher P. Denton, Carol M. Black,
and David J. Abra |
|
Research |
|
From Arthritis
Research & Therapy
"Clinical
Evaluation of Autoantibodies to a Novel PM/Scl
Peptide Antigen" (2005)
by Michael Mahler; Reinout Raijmakers; Cornelia
Dähnrich; Martin Blüthner; Marvin J
Fritzler |
|
Article (5 sections) |
|
"A2B
Adenosine Receptor Activity is Reduced in Neutrophils
From Patients With Systemic Sclerosis" (2005)
by Laura Bazzichi; Letizia Trincavelli; Alessandra
Rossi; Francesca De Feo; Antonio Lucacchini; Stefano
Bombardieri; Claudia Martini |
|
Article (5 sections) |
|
"Cambridge
Antibody Technology and Genzyme Announce Preliminary
Results from Phase I/II Trial of CAT-192 for Scleroderma
(2004)"
by Cambridge Antibody Technology (CAT), News
Release
|
|
Press Release |
|
"Self-Assessment
Cases: Cutaneous Manifestations of Systemic Diseases"
(2004)
ACP Medicine |
|
Quiz |
|
"Autologous
Hematopoietic Stem Cell Transplant Promising for
Systemic Sclerosis" (2004)
by Laurie Barclay, M.D., reviewed by Gary D. Vogin,
M.D. |
|
Article |
|
"B
Cells as Therapeutic Targets for Rheumatic Diseases"
(2004)
By R. John Looney; Jennifer Anolik; Inãki
Sanz |
|
Article (6 sections) |
|
"Nifedipine
Decreases sVCAM-1 Concentrations and Oxidative
Stress in Systemic Sclerosis but Does Not Affect
the Concentrations of Vascular Endothelial Growth
Factor or its Soluble Receptor 1" (2004)
by Yannick Allanore1; Didier Borderie2;
Hervé Lemaréchal2; Ohvanesse
Garabed Ekindjian2; and André
Kahan1
1Paris V University, Department of
Rheumatology A, Assistance Publique Hôpitaux
de Paris, Cochin Hospital, Paris, France2,
Department of Biochemistry A, Assistance Publique
Hôpitaux de Paris, Cochin Hospital, Paris,
France |
|
Article (5 sections) |
|
"Scleroderma
– Pathogenesis and Treatment" (collection
of abstracts by various authors) (2004)
"Microchimerism: An Investigative Frontier
in Autoimmunity and Transplantation," Adams
KM, Nelson JL, JAMA. 2004;291:1127-1131 |
|
Abstract |
|
"Scleroderma
– Pathogenesis and Treatment" (collection
of abstracts by various authors) (2004)
"Insights Into the Molecular Mechanism
of Chronic Fibrosis: The Role of Connective Tissue
Growth Factor in Scleroderma," Leask A, Denton
CP, Abraham DJ, J Invest Dermatol. 2004;122:1-6 |
|
Abstract |
|
"Scleroderma
– Pathogenesis and Treatment" (collection
of abstracts by various authors) (2004)
"The TNF-863A Allele Strongly Associates
With Anticentromere Antibody Positivity in Scleroderma,"
Sato H, Lagan AL, Alexopoulou C, et al, Arthritis
Rheum. 2004;50:558-564 |
|
Abstract |
|
"Recent
Advances in Fibroblast Signaling and Biology in
Scleroderma" (2004)
Jaspreet Pannu and Maria Trojanowska, Division
of Rheumatology and Immunology, Medical University
of South Carolina, Charleston, South Carolina |
|
Article (10 sections) |
|
"Minocycline
is not effective in systemic sclerosis: Results
of an open-label multicenter trial" (2003)
Maureen D. Mayes 1 *, Daniel O'Donnell
2, Naomi F. Rothfield 3,
M. E. Csuka 4
1 University of Texas-Houston Health
Science Center
2 Wayne State University School of
Medicine, Detroit, Michigan
3 University of Connecticut, Farmington
1 Medical College of Wisconsin, Milwaukee
|
|
Abstract |
|
Age
and Risk of Pulmonary Arterial Hypertension in
Scleroderma (2003)
by Lionel Schachna, MBBS, FRACP, Ph.D.; Fredrick
M. Wigley, M.D.; Betty Chang, M.D., CM, Ph.D.;
Barbara White, M.D.; Robert A. Wise, M.D., FCCP
and Allan C. Gelber, M.D., MPH, Ph.D. From the
Divisions of Rheumatology (Drs. Schachna, Wigley,
and Gelber) and Pulmonary and Critical Care Medicine
(Drs. Chang and Wise), Johns Hopkins University
School of Medicine; and Division of Rheumatology,
University of Maryland School of Medicine (Dr.
White), Baltimore, Maryland. |
|
Article (9 pages) |
|
"Intense
Immunosuppression and Stem-Cell Transplantation
for Patients With Severe Rheumatic Autoimmune
Disease: A Review" (2003)
by Jacob M. van Laar, M.D., Alan Tyndall,
M.D. |
|
Article (7 sections) |
|
Highlights
of the Annual European Congress of Rheumatology
European League Against Rheumatism (EULAR 2003)—a
Canadian Thought-Leader Perspective [Section 4]
(2003)
François Couture, M.D., FRACP(C), Medical
Consulting Rheumatologist, Hôpital Maisonneuve
Rosemont, University of Montreal, Montreal, Quebec,
CanadaJean-Pierre Mathieu, M.D., Assistant Clinical
Professor, Department of Medicine, University
of Montreal, Montreal, Quebec, Canada; Staff Physician,
Rheumatology, Hôpital Maisonneuve Rosemont,
Montreal, Quebec, Canada |
|
Highlights |
|
"Gender
Differences in Collagen Diseases" (2003)
Einat Tamir, M.D., Sarah Brenner, M.D., Department
of Dermatology, Tel Aviv Sourasky Medical Center,
and Sackler Faculty of Medicine, Tel Aviv University,
Israel |
|
Article (5 sections) |
|
"Autoimmunity
on Scleroderma: The Origin, Pathogenic Role, and
Clinical Significance of Autoantibodies"
(2003)
Michelle L. Harrisa and Antony
Rosena
baDepartment of Medicine,
Division of Rheumatology and bDepartment
of Cell Biology and Department of Pathology. Johns
Hopkins University School of Medicine, Baltimore,
Maryland |
|
Article (8 sections) |
|
Severe
Organ Involvement in Systemic Sclerosis with Diffuse
Scleroderma (2001) posted March
16, 2006
by Virginia D. Steen 1 *, Thomas A.
Medsger Jr. 2
1 Georgetown University, Washington,
D.C.; 2University of Pittsburgh, Pittsburgh,
Pennsylvania |
|
Abstract |
|
"42nd
Annual Meeting of the American Society of Hematology:
Stem Cell Transplants for Autoimmune Diseases:
What Next?" (2000)
by John R. Wingard, M.D., Michelle L. Plante,
PharmD |
|
Highlights |
|
MEDLINE
Abstracts: "UVA1 Phototherapy" (2000)
by Morita A, Kobayashi K, Isomura I, Tsuji T,
Krutmann J, J Am Acad Dermatol. 2000;43:670-674 |
|
Abstract |
|
"Scleroderma"
(1999)
by Lawrence F. Eichenfield, M.D. |
|
Conference recap |
|
"Rapid
Progression of Scleroderma Possibly Associated
with Penicillamine Therapy" from Clinical
Drug Investigation™ (1998)
by Yosef S. Haviv, Rifaat Safadi, Division of
Medicine, Hadassah Hebrew University Medical Center,
Jerusalem, Israel |
|
Article (3 sections) |
|
|
